Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer

M. S. Al-Moundhri, I. Al-Hadabi, K. Al-Mawaly, S. Kumar, F. A R Al-Lawati, G. Bhatnager, S. Kuruvila, A. Al-Hamdani, S. M. El-Sayed, B. Al-Bahrani

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Gastric cancer remains a significant global health burden with poor treatment outcome. New treatment modalities that target inflammation, proliferation, and angiogenesis have been used in various cancers, including gastric cancer. We sought to study the pattern of expression of two important proteins, cyclooxygenase-2 and epidermal growth factor receptor, and their association with microvascular density, clinicopathological features, and survival in Arab Omani patients with gastric cancer. Formalin-fixed, paraffinembedded tumors were studied by immunohistochemistry using monoclonal antibodies to cyclooxygenase-2, epidermal growth factor receptor, and CD34. The immunohistochemical results were correlated with clinicopathological features and survival. In our study population, we found a male/female ratio of 72:43, a median age of 59 years, stage III and IV incidence of 66.9%, and a median follow-up of 96 months. Positive expression rates of cyclooxygenase-2 and epidermal growth factor receptor were 89.6 and 23.5%, respectively. The median microvascular density value was 52.5. When this value was determined as the cut-off point, 50% of patients were found to have high microvascular density. Epidermal growth factor receptor over-expression correlated with high microvascular density values, advanced lymph node involvement (N3), and TNM stage presentation (III and IV). Similarly, lymph node involvement was associated with cyclooxygenase-2 over-expression and high microvascular density. Univariate analysis showed that epidermal growth factor receptor over-expression, pathological T3 and T4 disease, and overall stage III and IV disease were adverse prognostic factors. On multivariate analysis using a Cox regression model, expression of epidermal growth factor receptor, and advanced TNM stage were significant adverse prognostic factors for overall survival. Expression of epidermal growth factor receptor in Arab Omani patients with gastric cancer correlates with aggressive tumor characteristics and is an independent prognostic factor. Further clinical studies are needed to evaluate the utility of epidermal growth factor receptor immunohistochemistry as a tool for gastric cancer treatment.

Original languageEnglish
Pages (from-to)1739-1747
Number of pages9
JournalMedical Oncology
Volume29
Issue number3
DOIs
Publication statusPublished - Sep 2012

Fingerprint

Cyclooxygenase 2
Epidermal Growth Factor Receptor
Stomach Neoplasms
Survival
Lymph Nodes
Immunohistochemistry
Proportional Hazards Models
Formaldehyde
Neoplasms
Multivariate Analysis
Monoclonal Antibodies
Inflammation
Incidence
Therapeutics
Population

Keywords

  • Arabs
  • CD34
  • COX-2
  • EGFR1
  • Gastric cancer
  • Immunohistochemistry
  • Prognosis
  • Stomach

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Hematology

Cite this

Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer. / Al-Moundhri, M. S.; Al-Hadabi, I.; Al-Mawaly, K.; Kumar, S.; Al-Lawati, F. A R; Bhatnager, G.; Kuruvila, S.; Al-Hamdani, A.; El-Sayed, S. M.; Al-Bahrani, B.

In: Medical Oncology, Vol. 29, No. 3, 09.2012, p. 1739-1747.

Research output: Contribution to journalArticle

Al-Moundhri, M. S. ; Al-Hadabi, I. ; Al-Mawaly, K. ; Kumar, S. ; Al-Lawati, F. A R ; Bhatnager, G. ; Kuruvila, S. ; Al-Hamdani, A. ; El-Sayed, S. M. ; Al-Bahrani, B. / Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer. In: Medical Oncology. 2012 ; Vol. 29, No. 3. pp. 1739-1747.
@article{ada40534ae084d3996dd857afb9828f8,
title = "Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer",
abstract = "Gastric cancer remains a significant global health burden with poor treatment outcome. New treatment modalities that target inflammation, proliferation, and angiogenesis have been used in various cancers, including gastric cancer. We sought to study the pattern of expression of two important proteins, cyclooxygenase-2 and epidermal growth factor receptor, and their association with microvascular density, clinicopathological features, and survival in Arab Omani patients with gastric cancer. Formalin-fixed, paraffinembedded tumors were studied by immunohistochemistry using monoclonal antibodies to cyclooxygenase-2, epidermal growth factor receptor, and CD34. The immunohistochemical results were correlated with clinicopathological features and survival. In our study population, we found a male/female ratio of 72:43, a median age of 59 years, stage III and IV incidence of 66.9{\%}, and a median follow-up of 96 months. Positive expression rates of cyclooxygenase-2 and epidermal growth factor receptor were 89.6 and 23.5{\%}, respectively. The median microvascular density value was 52.5. When this value was determined as the cut-off point, 50{\%} of patients were found to have high microvascular density. Epidermal growth factor receptor over-expression correlated with high microvascular density values, advanced lymph node involvement (N3), and TNM stage presentation (III and IV). Similarly, lymph node involvement was associated with cyclooxygenase-2 over-expression and high microvascular density. Univariate analysis showed that epidermal growth factor receptor over-expression, pathological T3 and T4 disease, and overall stage III and IV disease were adverse prognostic factors. On multivariate analysis using a Cox regression model, expression of epidermal growth factor receptor, and advanced TNM stage were significant adverse prognostic factors for overall survival. Expression of epidermal growth factor receptor in Arab Omani patients with gastric cancer correlates with aggressive tumor characteristics and is an independent prognostic factor. Further clinical studies are needed to evaluate the utility of epidermal growth factor receptor immunohistochemistry as a tool for gastric cancer treatment.",
keywords = "Arabs, CD34, COX-2, EGFR1, Gastric cancer, Immunohistochemistry, Prognosis, Stomach",
author = "Al-Moundhri, {M. S.} and I. Al-Hadabi and K. Al-Mawaly and S. Kumar and Al-Lawati, {F. A R} and G. Bhatnager and S. Kuruvila and A. Al-Hamdani and El-Sayed, {S. M.} and B. Al-Bahrani",
year = "2012",
month = "9",
doi = "10.1007/s12032-011-0098-3",
language = "English",
volume = "29",
pages = "1739--1747",
journal = "Medical Oncology",
issn = "1357-0560",
publisher = "Humana Press",
number = "3",

}

TY - JOUR

T1 - Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer

AU - Al-Moundhri, M. S.

AU - Al-Hadabi, I.

AU - Al-Mawaly, K.

AU - Kumar, S.

AU - Al-Lawati, F. A R

AU - Bhatnager, G.

AU - Kuruvila, S.

AU - Al-Hamdani, A.

AU - El-Sayed, S. M.

AU - Al-Bahrani, B.

PY - 2012/9

Y1 - 2012/9

N2 - Gastric cancer remains a significant global health burden with poor treatment outcome. New treatment modalities that target inflammation, proliferation, and angiogenesis have been used in various cancers, including gastric cancer. We sought to study the pattern of expression of two important proteins, cyclooxygenase-2 and epidermal growth factor receptor, and their association with microvascular density, clinicopathological features, and survival in Arab Omani patients with gastric cancer. Formalin-fixed, paraffinembedded tumors were studied by immunohistochemistry using monoclonal antibodies to cyclooxygenase-2, epidermal growth factor receptor, and CD34. The immunohistochemical results were correlated with clinicopathological features and survival. In our study population, we found a male/female ratio of 72:43, a median age of 59 years, stage III and IV incidence of 66.9%, and a median follow-up of 96 months. Positive expression rates of cyclooxygenase-2 and epidermal growth factor receptor were 89.6 and 23.5%, respectively. The median microvascular density value was 52.5. When this value was determined as the cut-off point, 50% of patients were found to have high microvascular density. Epidermal growth factor receptor over-expression correlated with high microvascular density values, advanced lymph node involvement (N3), and TNM stage presentation (III and IV). Similarly, lymph node involvement was associated with cyclooxygenase-2 over-expression and high microvascular density. Univariate analysis showed that epidermal growth factor receptor over-expression, pathological T3 and T4 disease, and overall stage III and IV disease were adverse prognostic factors. On multivariate analysis using a Cox regression model, expression of epidermal growth factor receptor, and advanced TNM stage were significant adverse prognostic factors for overall survival. Expression of epidermal growth factor receptor in Arab Omani patients with gastric cancer correlates with aggressive tumor characteristics and is an independent prognostic factor. Further clinical studies are needed to evaluate the utility of epidermal growth factor receptor immunohistochemistry as a tool for gastric cancer treatment.

AB - Gastric cancer remains a significant global health burden with poor treatment outcome. New treatment modalities that target inflammation, proliferation, and angiogenesis have been used in various cancers, including gastric cancer. We sought to study the pattern of expression of two important proteins, cyclooxygenase-2 and epidermal growth factor receptor, and their association with microvascular density, clinicopathological features, and survival in Arab Omani patients with gastric cancer. Formalin-fixed, paraffinembedded tumors were studied by immunohistochemistry using monoclonal antibodies to cyclooxygenase-2, epidermal growth factor receptor, and CD34. The immunohistochemical results were correlated with clinicopathological features and survival. In our study population, we found a male/female ratio of 72:43, a median age of 59 years, stage III and IV incidence of 66.9%, and a median follow-up of 96 months. Positive expression rates of cyclooxygenase-2 and epidermal growth factor receptor were 89.6 and 23.5%, respectively. The median microvascular density value was 52.5. When this value was determined as the cut-off point, 50% of patients were found to have high microvascular density. Epidermal growth factor receptor over-expression correlated with high microvascular density values, advanced lymph node involvement (N3), and TNM stage presentation (III and IV). Similarly, lymph node involvement was associated with cyclooxygenase-2 over-expression and high microvascular density. Univariate analysis showed that epidermal growth factor receptor over-expression, pathological T3 and T4 disease, and overall stage III and IV disease were adverse prognostic factors. On multivariate analysis using a Cox regression model, expression of epidermal growth factor receptor, and advanced TNM stage were significant adverse prognostic factors for overall survival. Expression of epidermal growth factor receptor in Arab Omani patients with gastric cancer correlates with aggressive tumor characteristics and is an independent prognostic factor. Further clinical studies are needed to evaluate the utility of epidermal growth factor receptor immunohistochemistry as a tool for gastric cancer treatment.

KW - Arabs

KW - CD34

KW - COX-2

KW - EGFR1

KW - Gastric cancer

KW - Immunohistochemistry

KW - Prognosis

KW - Stomach

UR - http://www.scopus.com/inward/record.url?scp=84872826041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872826041&partnerID=8YFLogxK

U2 - 10.1007/s12032-011-0098-3

DO - 10.1007/s12032-011-0098-3

M3 - Article

VL - 29

SP - 1739

EP - 1747

JO - Medical Oncology

JF - Medical Oncology

SN - 1357-0560

IS - 3

ER -